IRF2 and ductal breast carcinoma in situ: In one retrospective study, IRF-1 but not IRF-2 was found to be expressed in normal breast tissue, whereas levels of the former were shown to be lower and those of the latter higher in high-grade ductal carcinoma in situ (DCIS) and lymph node-positive invasive ductal cancer [80].